| May 15 |
PACB
|
Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases |
| May 14 |
QGEN
|
QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision support |
| May 14 |
ILMN
|
Illumina, Inc. (ILMN) RBC Capital Markets Global Healthcare (Transcript) |
| May 14 |
QGEN
|
QIAGEN (QGEN) Wins FDA Nod for QIAstat-Dx Respiratory Panel Plus |
| May 14 |
PACB
|
Pacific Biosciences to lay off 195 employees as part of cost cuts |
| May 14 |
HYPR
|
Hyperfine Inc (HYPR) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth and Challenges |
| May 13 |
HYPR
|
Hyperfine, Inc. (HYPR) Q1 2024 Earnings Call Transcript |
| May 13 |
HYPR
|
Hyperfine GAAP EPS of -$0.14, revenue of $3.3M |
| May 13 |
HYPR
|
Hyperfine, Inc. Reports First Quarter 2024 Financial Results |
| May 13 |
QGEN
|
QIAGEN gets FDA clearance for QIAstat-Dx Respiratory Panel Plus |
| May 13 |
QGEN
|
QIAGEN (QGEN) to Enhance Forensics With New Partnership |
| May 13 |
QGEN
|
Qiagen’s QIAstat-Dx respiratory diagnostic wins FDA clearance |
| May 13 |
QGEN
|
QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate results |
| May 11 |
QSI
|
Quantum-Si First Quarter 2024 Earnings: Beats Expectations |
| May 11 |
PACB
|
Pacific Biosciences of California First Quarter 2024 Earnings: Misses Expectations |
| May 10 |
PACB
|
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2024 Earnings Call Transcript |
| May 10 |
PACB
|
Pacific Biosciences of California Inc (PACB) Q1 2024 Earnings: Narrowing Losses but Misses ... |
| May 10 |
PACB
|
PacBio (PACB) Q1 Earnings In Line, Adjusted Gross Margin Up |
| May 10 |
HYPR
|
Hyperfine, Inc. to Expand Global Market Reach with Appointment of International Distributors in Key European Markets |
| May 10 |
QSI
|
Quantum-Si Incorporated (QSI) Q1 2024 Earnings Call Transcript |
